Global Nucleic Acid Isolation and Purification Market

Nucleic Acid Isolation and Purification Comprehensive Study by Type (Kits, Reagents, Instruments), Application (Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture & Animal Research, Other), Method Type (Column-based Isolation and Purification, Reagent-based Isolation and Purification, Magnetic Bead-based Isolation and Purification, Other Methods), End User (Research Centers and Academic & Government Institutes, Hospitals and Clinics, Pharmaceutical & Biotechnology Companies, Other) Players and Region - Global Market Outlook to 2028

Nucleic Acid Isolation and Purification Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 6.7%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Nucleic Acid Isolation and Purification Market?

Nucleic acid isolation and purification are one of the first steps in most molecular biology. There presents a wide variety of instruments and processes for nucleic acid extraction. Increasing advent of automation in research processes, there is a surging need for automatic nucleic acid extraction systems. Automated Nucleic Acid Extraction Systems provide high-speed, cleaner, and more consistent nucleic acid extraction.

Highlights from Nucleic Acid Isolation and Purification Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledAgilent Technologies (United States), QIAGEN (Netherlands), Illumina (United States), Takara Bio (Japan), Thermo Fisher Scientific (United States), Roche (Switzerland), Merck KGaA (Germany), Promega Corporation (United States), General Electric Company (United States), Danaher Corporation (United States), New England Biolabs (United States) and Bio-Rad Laboratories (United States)
CAGR6.7%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new product launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Nucleic Acid Isolation and Purification market throughout the forecasted period.

Agilent Technologies (United States), QIAGEN (Netherlands), Illumina (United States), Takara Bio (Japan), Thermo Fisher Scientific (United States), Roche (Switzerland), Merck KGaA (Germany), Promega Corporation (United States), General Electric Company (United States), Danaher Corporation (United States), New England Biolabs (United States) and Bio-Rad Laboratories (United States) are some of the key players profiled in the study.

Nucleic Acid Isolation and Purification Market Segmentation:
ScopeSub-Segments
Application / End UserDiagnostics, Drug Discovery and Development, Precision Medicine, Agriculture & Animal Research and Other
TypeKits, Reagents and Instruments
Method TypeColumn-based Isolation and Purification,Reagent-based Isolation and Purification,Magnetic Bead-based Isolation and Purification,Other Methods
End UserResearch Centers and Academic & Government Institutes,Hospitals and Clinics,Pharmaceutical & Biotechnology Companies,Other


On the basis of geography, the market of Nucleic Acid Isolation and Purification has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Trend of Molecular Diagnostics and Personalized Medicine Development and Technological Advancements and Increasing Automation

Market Growth Drivers:
Increasing Public-Private Funding for Life Science Research, Rise in the R&D Funding in Biotechnology and Healthcare and Surging Public and Private Partnerships in R&D in the Life Science and Biotechnology Industries

Challenges:
Low Penetration of this Technology in Emerging Countries

Restraints:
High Cost of Automated Instruments and Lack of Automation and Skilled Professionals in Developing Economies

Opportunities:
Wide-Range Applications of Nucleic Acid Testing in Diagnostics, Increasing Prevalence of Genetic Disorders, Cancer, and Infectious Diseases and Shifting from Being Product-Oriented to being a Service-Oriented Platform

Key Target Audience
Hospitals and Diagnostic Centers, Contract Research Organizations, Healthcare Institutions, Research Institutes, Pharmaceutical and Biotechnology Companies and Others

Market Leaders & Development Strategies
In 2020, Thermo Fisher acquired QIAGEN N.V., a provider of molecular diagnostics and sample preparation technologies. It is anticipated that the acquisition add innovative sample preparation, assay, and bioinformatics capabilities to the company's specialist portfolio.
In 2022, Thermo Fisher invested USD 97 million to expand its clinical research operations in Richmond, Virginia. The facility promotes clinical research programs by offering top-notch bioanalytical lab services.


Report Objectives / Segmentation Covered

By Type
  • Kits
  • Reagents
  • Instruments
By Application
  • Diagnostics
  • Drug Discovery and Development
  • Precision Medicine
  • Agriculture & Animal Research
  • Other
By Method Type
  • Column-based Isolation and Purification
  • Reagent-based Isolation and Purification
  • Magnetic Bead-based Isolation and Purification
  • Other Methods

By End User
  • Research Centers and Academic & Government Institutes
  • Hospitals and Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Public-Private Funding for Life Science Research
      • 3.2.2. Rise in the R&D Funding in Biotechnology and Healthcare
      • 3.2.3. Surging Public and Private Partnerships in R&D in the Life Science and Biotechnology Industries
    • 3.3. Market Challenges
      • 3.3.1. Low Penetration of this Technology in Emerging Countries
    • 3.4. Market Trends
      • 3.4.1. Increasing Trend of Molecular Diagnostics and Personalized Medicine Development
      • 3.4.2. Technological Advancements and Increasing Automation
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Nucleic Acid Isolation and Purification, by Type, Application, Method Type, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Nucleic Acid Isolation and Purification (Value)
      • 5.2.1. Global Nucleic Acid Isolation and Purification by: Type (Value)
        • 5.2.1.1. Kits
        • 5.2.1.2. Reagents
        • 5.2.1.3. Instruments
      • 5.2.2. Global Nucleic Acid Isolation and Purification by: Application (Value)
        • 5.2.2.1. Diagnostics
        • 5.2.2.2. Drug Discovery and Development
        • 5.2.2.3. Precision Medicine
        • 5.2.2.4. Agriculture & Animal Research
        • 5.2.2.5. Other
      • 5.2.3. Global Nucleic Acid Isolation and Purification by: Method Type (Value)
        • 5.2.3.1. Column-based Isolation and Purification
        • 5.2.3.2. Reagent-based Isolation and Purification
        • 5.2.3.3. Magnetic Bead-based Isolation and Purification
        • 5.2.3.4. Other Methods
      • 5.2.4. Global Nucleic Acid Isolation and Purification by: End User (Value)
        • 5.2.4.1. Research Centers and Academic & Government Institutes
        • 5.2.4.2. Hospitals and Clinics
        • 5.2.4.3. Pharmaceutical & Biotechnology Companies
        • 5.2.4.4. Other
      • 5.2.5. Global Nucleic Acid Isolation and Purification Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Nucleic Acid Isolation and Purification: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Agilent Technologies (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. QIAGEN (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Illumina (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Takara Bio (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Thermo Fisher Scientific (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Roche (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Merck KGaA (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Promega Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. General Electric Company (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Danaher Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. New England Biolabs (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Bio-Rad Laboratories (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Nucleic Acid Isolation and Purification Sale, by Type, Application, Method Type, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Nucleic Acid Isolation and Purification (Value)
      • 7.2.1. Global Nucleic Acid Isolation and Purification by: Type (Value)
        • 7.2.1.1. Kits
        • 7.2.1.2. Reagents
        • 7.2.1.3. Instruments
      • 7.2.2. Global Nucleic Acid Isolation and Purification by: Application (Value)
        • 7.2.2.1. Diagnostics
        • 7.2.2.2. Drug Discovery and Development
        • 7.2.2.3. Precision Medicine
        • 7.2.2.4. Agriculture & Animal Research
        • 7.2.2.5. Other
      • 7.2.3. Global Nucleic Acid Isolation and Purification by: Method Type (Value)
        • 7.2.3.1. Column-based Isolation and Purification
        • 7.2.3.2. Reagent-based Isolation and Purification
        • 7.2.3.3. Magnetic Bead-based Isolation and Purification
        • 7.2.3.4. Other Methods
      • 7.2.4. Global Nucleic Acid Isolation and Purification by: End User (Value)
        • 7.2.4.1. Research Centers and Academic & Government Institutes
        • 7.2.4.2. Hospitals and Clinics
        • 7.2.4.3. Pharmaceutical & Biotechnology Companies
        • 7.2.4.4. Other
      • 7.2.5. Global Nucleic Acid Isolation and Purification Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Nucleic Acid Isolation and Purification: by Type(USD Million)
  • Table 2. Nucleic Acid Isolation and Purification Kits , by Region USD Million (2017-2022)
  • Table 3. Nucleic Acid Isolation and Purification Reagents , by Region USD Million (2017-2022)
  • Table 4. Nucleic Acid Isolation and Purification Instruments , by Region USD Million (2017-2022)
  • Table 5. Nucleic Acid Isolation and Purification: by Application(USD Million)
  • Table 6. Nucleic Acid Isolation and Purification Diagnostics , by Region USD Million (2017-2022)
  • Table 7. Nucleic Acid Isolation and Purification Drug Discovery and Development , by Region USD Million (2017-2022)
  • Table 8. Nucleic Acid Isolation and Purification Precision Medicine , by Region USD Million (2017-2022)
  • Table 9. Nucleic Acid Isolation and Purification Agriculture & Animal Research , by Region USD Million (2017-2022)
  • Table 10. Nucleic Acid Isolation and Purification Other , by Region USD Million (2017-2022)
  • Table 11. Nucleic Acid Isolation and Purification: by Method Type(USD Million)
  • Table 12. Nucleic Acid Isolation and Purification Column-based Isolation and Purification , by Region USD Million (2017-2022)
  • Table 13. Nucleic Acid Isolation and Purification Reagent-based Isolation and Purification , by Region USD Million (2017-2022)
  • Table 14. Nucleic Acid Isolation and Purification Magnetic Bead-based Isolation and Purification , by Region USD Million (2017-2022)
  • Table 15. Nucleic Acid Isolation and Purification Other Methods , by Region USD Million (2017-2022)
  • Table 16. Nucleic Acid Isolation and Purification: by End User(USD Million)
  • Table 17. Nucleic Acid Isolation and Purification Research Centers and Academic & Government Institutes , by Region USD Million (2017-2022)
  • Table 18. Nucleic Acid Isolation and Purification Hospitals and Clinics , by Region USD Million (2017-2022)
  • Table 19. Nucleic Acid Isolation and Purification Pharmaceutical & Biotechnology Companies , by Region USD Million (2017-2022)
  • Table 20. Nucleic Acid Isolation and Purification Other , by Region USD Million (2017-2022)
  • Table 21. South America Nucleic Acid Isolation and Purification, by Country USD Million (2017-2022)
  • Table 22. South America Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 23. South America Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 24. South America Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 25. South America Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 26. Brazil Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 27. Brazil Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 28. Brazil Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 29. Brazil Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 30. Argentina Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 31. Argentina Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 32. Argentina Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 33. Argentina Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 34. Rest of South America Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 35. Rest of South America Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 36. Rest of South America Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 37. Rest of South America Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 38. Asia Pacific Nucleic Acid Isolation and Purification, by Country USD Million (2017-2022)
  • Table 39. Asia Pacific Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 40. Asia Pacific Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 41. Asia Pacific Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 42. Asia Pacific Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 43. China Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 44. China Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 45. China Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 46. China Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 47. Japan Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 48. Japan Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 49. Japan Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 50. Japan Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 51. India Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 52. India Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 53. India Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 54. India Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 55. South Korea Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 56. South Korea Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 57. South Korea Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 58. South Korea Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 59. Taiwan Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 60. Taiwan Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 61. Taiwan Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 62. Taiwan Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 63. Australia Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 64. Australia Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 65. Australia Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 66. Australia Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 67. Rest of Asia-Pacific Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 69. Rest of Asia-Pacific Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 70. Rest of Asia-Pacific Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 71. Europe Nucleic Acid Isolation and Purification, by Country USD Million (2017-2022)
  • Table 72. Europe Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 73. Europe Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 74. Europe Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 75. Europe Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 76. Germany Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 77. Germany Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 78. Germany Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 79. Germany Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 80. France Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 81. France Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 82. France Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 83. France Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 84. Italy Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 85. Italy Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 86. Italy Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 87. Italy Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 88. United Kingdom Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 89. United Kingdom Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 90. United Kingdom Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 91. United Kingdom Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 92. Netherlands Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 93. Netherlands Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 94. Netherlands Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 95. Netherlands Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 96. Rest of Europe Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 97. Rest of Europe Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 98. Rest of Europe Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 99. Rest of Europe Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 100. MEA Nucleic Acid Isolation and Purification, by Country USD Million (2017-2022)
  • Table 101. MEA Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 102. MEA Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 103. MEA Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 104. MEA Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 105. Middle East Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 106. Middle East Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 107. Middle East Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 108. Middle East Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 109. Africa Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 110. Africa Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 111. Africa Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 112. Africa Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 113. North America Nucleic Acid Isolation and Purification, by Country USD Million (2017-2022)
  • Table 114. North America Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 115. North America Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 116. North America Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 117. North America Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 118. United States Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 119. United States Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 120. United States Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 121. United States Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 122. Canada Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 123. Canada Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 124. Canada Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 125. Canada Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 126. Mexico Nucleic Acid Isolation and Purification, by Type USD Million (2017-2022)
  • Table 127. Mexico Nucleic Acid Isolation and Purification, by Application USD Million (2017-2022)
  • Table 128. Mexico Nucleic Acid Isolation and Purification, by Method Type USD Million (2017-2022)
  • Table 129. Mexico Nucleic Acid Isolation and Purification, by End User USD Million (2017-2022)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Nucleic Acid Isolation and Purification: by Type(USD Million)
  • Table 143. Nucleic Acid Isolation and Purification Kits , by Region USD Million (2023-2028)
  • Table 144. Nucleic Acid Isolation and Purification Reagents , by Region USD Million (2023-2028)
  • Table 145. Nucleic Acid Isolation and Purification Instruments , by Region USD Million (2023-2028)
  • Table 146. Nucleic Acid Isolation and Purification: by Application(USD Million)
  • Table 147. Nucleic Acid Isolation and Purification Diagnostics , by Region USD Million (2023-2028)
  • Table 148. Nucleic Acid Isolation and Purification Drug Discovery and Development , by Region USD Million (2023-2028)
  • Table 149. Nucleic Acid Isolation and Purification Precision Medicine , by Region USD Million (2023-2028)
  • Table 150. Nucleic Acid Isolation and Purification Agriculture & Animal Research , by Region USD Million (2023-2028)
  • Table 151. Nucleic Acid Isolation and Purification Other , by Region USD Million (2023-2028)
  • Table 152. Nucleic Acid Isolation and Purification: by Method Type(USD Million)
  • Table 153. Nucleic Acid Isolation and Purification Column-based Isolation and Purification , by Region USD Million (2023-2028)
  • Table 154. Nucleic Acid Isolation and Purification Reagent-based Isolation and Purification , by Region USD Million (2023-2028)
  • Table 155. Nucleic Acid Isolation and Purification Magnetic Bead-based Isolation and Purification , by Region USD Million (2023-2028)
  • Table 156. Nucleic Acid Isolation and Purification Other Methods , by Region USD Million (2023-2028)
  • Table 157. Nucleic Acid Isolation and Purification: by End User(USD Million)
  • Table 158. Nucleic Acid Isolation and Purification Research Centers and Academic & Government Institutes , by Region USD Million (2023-2028)
  • Table 159. Nucleic Acid Isolation and Purification Hospitals and Clinics , by Region USD Million (2023-2028)
  • Table 160. Nucleic Acid Isolation and Purification Pharmaceutical & Biotechnology Companies , by Region USD Million (2023-2028)
  • Table 161. Nucleic Acid Isolation and Purification Other , by Region USD Million (2023-2028)
  • Table 162. South America Nucleic Acid Isolation and Purification, by Country USD Million (2023-2028)
  • Table 163. South America Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 164. South America Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 165. South America Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 166. South America Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 167. Brazil Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 168. Brazil Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 169. Brazil Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 170. Brazil Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 171. Argentina Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 172. Argentina Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 173. Argentina Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 174. Argentina Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 175. Rest of South America Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 176. Rest of South America Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 177. Rest of South America Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 178. Rest of South America Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 179. Asia Pacific Nucleic Acid Isolation and Purification, by Country USD Million (2023-2028)
  • Table 180. Asia Pacific Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 181. Asia Pacific Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 182. Asia Pacific Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 183. Asia Pacific Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 184. China Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 185. China Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 186. China Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 187. China Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 188. Japan Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 189. Japan Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 190. Japan Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 191. Japan Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 192. India Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 193. India Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 194. India Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 195. India Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 196. South Korea Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 197. South Korea Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 198. South Korea Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 199. South Korea Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 200. Taiwan Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 201. Taiwan Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 202. Taiwan Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 203. Taiwan Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 204. Australia Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 205. Australia Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 206. Australia Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 207. Australia Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 208. Rest of Asia-Pacific Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 209. Rest of Asia-Pacific Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 210. Rest of Asia-Pacific Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 211. Rest of Asia-Pacific Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 212. Europe Nucleic Acid Isolation and Purification, by Country USD Million (2023-2028)
  • Table 213. Europe Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 214. Europe Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 215. Europe Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 216. Europe Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 217. Germany Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 218. Germany Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 219. Germany Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 220. Germany Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 221. France Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 222. France Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 223. France Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 224. France Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 225. Italy Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 226. Italy Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 227. Italy Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 228. Italy Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 229. United Kingdom Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 230. United Kingdom Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 231. United Kingdom Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 232. United Kingdom Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 233. Netherlands Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 234. Netherlands Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 235. Netherlands Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 236. Netherlands Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 237. Rest of Europe Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 238. Rest of Europe Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 239. Rest of Europe Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 240. Rest of Europe Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 241. MEA Nucleic Acid Isolation and Purification, by Country USD Million (2023-2028)
  • Table 242. MEA Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 243. MEA Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 244. MEA Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 245. MEA Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 246. Middle East Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 247. Middle East Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 248. Middle East Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 249. Middle East Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 250. Africa Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 251. Africa Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 252. Africa Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 253. Africa Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 254. North America Nucleic Acid Isolation and Purification, by Country USD Million (2023-2028)
  • Table 255. North America Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 256. North America Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 257. North America Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 258. North America Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 259. United States Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 260. United States Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 261. United States Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 262. United States Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 263. Canada Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 264. Canada Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 265. Canada Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 266. Canada Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 267. Mexico Nucleic Acid Isolation and Purification, by Type USD Million (2023-2028)
  • Table 268. Mexico Nucleic Acid Isolation and Purification, by Application USD Million (2023-2028)
  • Table 269. Mexico Nucleic Acid Isolation and Purification, by Method Type USD Million (2023-2028)
  • Table 270. Mexico Nucleic Acid Isolation and Purification, by End User USD Million (2023-2028)
  • Table 271. Research Programs/Design for This Report
  • Table 272. Key Data Information from Secondary Sources
  • Table 273. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Nucleic Acid Isolation and Purification: by Type USD Million (2017-2022)
  • Figure 5. Global Nucleic Acid Isolation and Purification: by Application USD Million (2017-2022)
  • Figure 6. Global Nucleic Acid Isolation and Purification: by Method Type USD Million (2017-2022)
  • Figure 7. Global Nucleic Acid Isolation and Purification: by End User USD Million (2017-2022)
  • Figure 8. South America Nucleic Acid Isolation and Purification Share (%), by Country
  • Figure 9. Asia Pacific Nucleic Acid Isolation and Purification Share (%), by Country
  • Figure 10. Europe Nucleic Acid Isolation and Purification Share (%), by Country
  • Figure 11. MEA Nucleic Acid Isolation and Purification Share (%), by Country
  • Figure 12. North America Nucleic Acid Isolation and Purification Share (%), by Country
  • Figure 13. Global Nucleic Acid Isolation and Purification share by Players 2022 (%)
  • Figure 14. Global Nucleic Acid Isolation and Purification share by Players (Top 3) 2022(%)
  • Figure 15. Global Nucleic Acid Isolation and Purification share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 18. Agilent Technologies (United States) Revenue: by Geography 2022
  • Figure 19. QIAGEN (Netherlands) Revenue, Net Income and Gross profit
  • Figure 20. QIAGEN (Netherlands) Revenue: by Geography 2022
  • Figure 21. Illumina (United States) Revenue, Net Income and Gross profit
  • Figure 22. Illumina (United States) Revenue: by Geography 2022
  • Figure 23. Takara Bio (Japan) Revenue, Net Income and Gross profit
  • Figure 24. Takara Bio (Japan) Revenue: by Geography 2022
  • Figure 25. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 26. Thermo Fisher Scientific (United States) Revenue: by Geography 2022
  • Figure 27. Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. Roche (Switzerland) Revenue: by Geography 2022
  • Figure 29. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Merck KGaA (Germany) Revenue: by Geography 2022
  • Figure 31. Promega Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Promega Corporation (United States) Revenue: by Geography 2022
  • Figure 33. General Electric Company (United States) Revenue, Net Income and Gross profit
  • Figure 34. General Electric Company (United States) Revenue: by Geography 2022
  • Figure 35. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Danaher Corporation (United States) Revenue: by Geography 2022
  • Figure 37. New England Biolabs (United States) Revenue, Net Income and Gross profit
  • Figure 38. New England Biolabs (United States) Revenue: by Geography 2022
  • Figure 39. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 40. Bio-Rad Laboratories (United States) Revenue: by Geography 2022
  • Figure 41. Global Nucleic Acid Isolation and Purification: by Type USD Million (2023-2028)
  • Figure 42. Global Nucleic Acid Isolation and Purification: by Application USD Million (2023-2028)
  • Figure 43. Global Nucleic Acid Isolation and Purification: by Method Type USD Million (2023-2028)
  • Figure 44. Global Nucleic Acid Isolation and Purification: by End User USD Million (2023-2028)
  • Figure 45. South America Nucleic Acid Isolation and Purification Share (%), by Country
  • Figure 46. Asia Pacific Nucleic Acid Isolation and Purification Share (%), by Country
  • Figure 47. Europe Nucleic Acid Isolation and Purification Share (%), by Country
  • Figure 48. MEA Nucleic Acid Isolation and Purification Share (%), by Country
  • Figure 49. North America Nucleic Acid Isolation and Purification Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Agilent Technologies (United States)
  • QIAGEN (Netherlands)
  • Illumina (United States)
  • Takara Bio (Japan)
  • Thermo Fisher Scientific (United States)
  • Roche (Switzerland)
  • Merck KGaA (Germany)
  • Promega Corporation (United States)
  • General Electric Company (United States)
  • Danaher Corporation (United States)
  • New England Biolabs (United States)
  • Bio-Rad Laboratories (United States)
Select User Access Type

Key Highlights of Report


Jun 2023 227 Pages 61 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Nucleic Acid Isolation and Purification Market Quantitative research analysis
Global Nucleic Acid Isolation and Purification Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increasing Public-Private Funding for Life Science Research " is seen as one of major growth factors of Nucleic Acid Isolation and Purification Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Nucleic Acid Isolation and Purification market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Nucleic Acid Isolation and Purification Market Report?

Have a Query? Click Here

Other Related Reports

Probiotics Tablets Comprehensive Study by Type (Digestive Support, Immune Support), Function (Regular, Preventive, Therapeutic), Ingredient (Bacteria, Yeast), End User (Child, Adult) Players and Regi...
$ 3500
NGS Sample Preparation Comprehensive Study by Application (Whole Genome Sequence (WGS), Exome Sequencing, RNA Sequencing, Methylation Sequencing), Workflow  (Library Preparation, Cluster Generation, ...
$ 3750
Gram Staining System Comprehensive Study by Type (Gram Staining System Regents, Automated Gram Staining System, Accessories), Application (Contract Research Organizations, Diagnostic Laboratories, Ho...
$ 3350
Genome Engineering Comprehensive Study by Type (Reagents & Consumables, Software & Systems, Services), Application (Cell Line Engineering , Animal Genetic Engineering , Plant Genetic Engineering , Ot...
$ 3750
Cell Viability Assays Comprehensive Study by Type (Human Cells, Microbial Cells, Animal Cells), Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Ap...
$ 3650
Nutrigenomics Comprehensive Study by Type (Reagents & kits, Services), Application (Obesity, Diabetes, Anti-Aging, Chronic Diseases), Techniques (Saliva, Buccal Swab, Blood, Others) Players and Regio...
$ 3500